Irnocam 100MG Injection (2ml) is a chemotherapy medication primarily used in the treatment of various types of cancer, including colorectal cancer and small cell lung cancer. The active ingredient in this injection is Irinotecan, which is a topoisomerase inhibitor that interferes with the DNA replication process in cancer cells, ultimately leading to cell death. Each 2ml vial of Irnocam contains 100mg of Irinotecan, formulated to provide effective treatment while minimizing the risk of side effects. This medication is typically administered intravenously under the supervision of a healthcare professional, ensuring that patients receive the correct dosage and monitoring for any adverse reactions. Irnocam is an essential component of combination chemotherapy regimens, enhancing the effectiveness of other anticancer agents and improving overall treatment outcomes for patients battling cancer.

Campto 100MG Injection (5ml) is a chemotherapy medication that contains the active ingredient Irinotecan, which is primarily used in the treatment of various types of cancer, particularly colorectal cancer. This drug works by inhibiting the enzyme topoisomerase I, which is crucial for DNA replication and repair, thereby preventing cancer cells from dividing and growing. The injection is typically administered intravenously under the supervision of a healthcare professional, ensuring that patients receive the correct dosage and monitoring for any adverse effects. Campto is often part of a combination therapy, enhancing its effectiveness when used alongside other anticancer agents. The formulation is designed to deliver a potent dose of 100mg of Irinotecan in a 5ml solution, making it a critical component in the oncological treatment arsenal.